Data as of Oct 24
| 0.00 / 0.00%|
The 14 analysts offering 12-month price forecasts for Impax Laboratories Inc have a median target of 28.50, with a high estimate of 40.00 and a low estimate of 23.00. The median estimate represents a +2.52% increase from the last price of 27.80.
The current consensus among 15 polled investment analysts is to Hold stock in Impax Laboratories Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.